Considerations in Prescribing Dupilumab

• Cost and coverage important considerations
• For insurance to cover, clinicians must document:
  • Diagnosis of AD (not just "eczema")
  • Condition severity
  • Prior treatments and failures
    • Specify the type of failure
    • Inadequate response to medium- or high-potency TCS, suboptimal improvement, failure to achieve long-term control, unacceptable adverse events
  • Impact of disease on QOL